Leyuan Ma

2.0k total citations · 3 hit papers
30 papers, 1.5k citations indexed

About

Leyuan Ma is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Leyuan Ma has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Hematology. Recurrent topics in Leyuan Ma's work include CAR-T cell therapy research (7 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Immunotherapy and Immune Responses (5 papers). Leyuan Ma is often cited by papers focused on CAR-T cell therapy research (7 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Immunotherapy and Immune Responses (5 papers). Leyuan Ma collaborates with scholars based in United States, China and Germany. Leyuan Ma's co-authors include Darrell J. Irvine, Michael R. Green, Naveen K. Mehta, K. Dane Wittrup, Lihua Julie Zhu, Wuhbet Abraham, Na Li, Zhi Sheng, Jiaoyuan Elisabeth Sun and Cheng-Qiang He and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Leyuan Ma

29 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhanced CAR–T cell activity against solid tumors by vaccine boosting through the chimeric receptor

2019 319 citations Leyuan Ma, Tanmay Dichwalkar et al. Science profile →
STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity

2022 242 citations Eric L. Dane, Alexis Belessiotis‐Richards et al. Nature Materials profile →
Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity

2023 128 citations Leyuan Ma, Duncan M. Morgan et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leyuan Ma United States	15	584	566	516	267	184	30	1.5k
Qingfeng Chen Singapore	25	816 1.4×	623 1.1×	574 1.1×	288 1.1×	237 1.3×	72	2.1k
Ryan Basom United States	21	734 1.3×	1.1k 1.9×	834 1.6×	123 0.5×	233 1.3×	49	2.2k
Mostafa Jarahian Germany	15	679 1.2×	444 0.8×	635 1.2×	167 0.6×	93 0.5×	25	1.4k
Michael Klichinsky United States	14	902 1.5×	586 1.0×	1.3k 2.6×	315 1.2×	145 0.8×	56	2.0k
Xing He China	16	546 0.9×	455 0.8×	679 1.3×	182 0.7×	102 0.6×	35	1.6k
Pontus Blomberg Sweden	22	412 0.7×	836 1.5×	219 0.4×	132 0.5×	116 0.6×	44	1.6k
Michael Aigner Germany	22	588 1.0×	440 0.8×	469 0.9×	112 0.4×	136 0.7×	81	1.4k
John F. Whitesides United States	16	733 1.3×	309 0.5×	364 0.7×	124 0.5×	135 0.7×	35	1.5k
Jillian L. Astarita United States	12	1.2k 2.0×	900 1.6×	1.2k 2.3×	206 0.8×	102 0.6×	17	2.7k

Countries citing papers authored by Leyuan Ma

Since Specialization

Citations

This map shows the geographic impact of Leyuan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leyuan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leyuan Ma more than expected).

Fields of papers citing papers by Leyuan Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leyuan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leyuan Ma. The network helps show where Leyuan Ma may publish in the future.

Co-authorship network of co-authors of Leyuan Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Leyuan Ma. A scholar is included among the top collaborators of Leyuan Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leyuan Ma. Leyuan Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yunpeng, Zhen Yu, Leyuan Ma, et al.. (2025). Green and efficient fabrication of high-damping porous films for energy harvesting and self-powered sensing. Journal of Colloid and Interface Science. 697. 137988–137988. 2 indexed citations

Zhong, Wenqun, Zhiyuan Qin, Ziyan Yu, et al.. (2025). Overcoming extracellular vesicle-mediated fratricide improves CAR T cell treatment against solid tumors. Nature Cancer. 6(7). 1157–1172. 3 indexed citations

Zhang, He, Leyuan Ma, Zhenmin Yuan, & Hexu Liu. (2024). Enhanced concrete crack detection and proactive safety warning based on I-ST-UNet model. Automation in Construction. 166. 105612–105612. 7 indexed citations

Chen, Kaige, et al.. (2024). Crosstalking with dendritic cells: a path to engineer advanced T Cell immunotherapy. SHILAP Revista de lepidopterología. 4. 3 indexed citations

Sun, Qiqi, Leyuan Ma, Xuehui Li, et al.. (2024). Molecule-Level Multiscale Design of Nonflammable Gel Polymer Electrolyte to Build Stable SEI/CEI for Lithium Metal Battery. Nano-Micro Letters. 17(1). 18–18. 15 indexed citations

Ma, Leyuan & T. Hartmann. (2024). Exploration of using a wall-climbing robot system for indoor inspection in occupied buildings. Scientific Reports. 14(1). 13770–13770. 1 indexed citations

Spear, Timothy T., David Groff, Kristopher R. Bosse, et al.. (2024). Abstract 5121: Next-generation immunocompetent and humanized neuroblastoma murine models for the discovery and validation of novel immunotherapies. Cancer Research. 84(6_Supplement). 5121–5121. 1 indexed citations

Ma, Leyuan, et al.. (2023). Copper-coated hollow glass microspheres filled rubber composites: Lightweight, interface bonding and mechanical properties. eXPRESS Polymer Letters. 17(5). 502–511. 1 indexed citations

Ma, Leyuan, Duncan M. Morgan, Laura Maiorino, et al.. (2023). Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity. Cell. 186(15). 3148–3165.e20. 128 indexed citations breakdown →

10.

Ma, Leyuan. (2023). 286 Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity. SHILAP Revista de lepidopterología. A327–A328. 2 indexed citations

11.

Dooling, Lawrence J., Jason C. Andrechak, William Zhang, et al.. (2023). Cooperative phagocytosis of solid tumours by macrophages triggers durable anti-tumour responses. Nature Biomedical Engineering. 7(9). 1081–1096. 36 indexed citations

12.

Dane, Eric L., Alexis Belessiotis‐Richards, Coralie M. Backlund, et al.. (2022). STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity. Nature Materials. 21(6). 710–720. 242 indexed citations breakdown →

13.

Momin, Noor, Naveen K. Mehta, Nitasha R. Bennett, et al.. (2019). Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy. Science Translational Medicine. 11(498). 158 indexed citations

14.

Ma, Leyuan, Tanmay Dichwalkar, Jason Y.H. Chang, et al.. (2019). Enhanced CAR–T cell activity against solid tumors by vaccine boosting through the chimeric receptor. Science. 365(6449). 162–168. 319 indexed citations breakdown →

15.

Park, Chun Shik, Taylor J Chen, Shen Ye, et al.. (2019). A KLF4-DYRK2–mediated pathway regulating self-renewal in CML stem cells. Blood. 134(22). 1960–1972. 36 indexed citations

16.

Ma, Leyuan, Justine E. Roderick, Michelle A. Kelliher, & Michael R. Green. (2016). High-Throughput Screening of Tyrosine Kinase Inhibitor Resistant Genes in CML. Methods in molecular biology. 1465. 159–173. 4 indexed citations

17.

Yang, Zhongfa, Haojian Zhang, Leyuan Ma, et al.. (2013). GABP transcription factor is required for development of chronic myelogenous leukemia via its control of PRKD2. Proceedings of the National Academy of Sciences. 110(6). 2312–2317. 22 indexed citations

18.

Han, Guan‐Zhu, Jie Dong, Decheng Wang, et al.. (2008). Homologous Recombination as an Evolutionary Force in the Avian Influenza A Virus. Molecular Biology and Evolution. 26(1). 177–187. 64 indexed citations

19.

He, Cheng-Qiang, Leyuan Ma, Dong Wang, Guorong Li, & Nai‐Zheng Ding. (2008). Homologous recombination is apparent in infectious bursal disease virus. Virology. 384(1). 51–58. 45 indexed citations

20.

Han, Guan‐Zhu, Cheng-Qiang He, Nai‐Zheng Ding, & Leyuan Ma. (2007). Identification of a natural multi-recombinant of Newcastle disease virus. Virology. 371(1). 54–60. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact